Guest guest Posted January 14, 2011 Report Share Posted January 14, 2011 She presented this at a confrence in 2008 maybe 09. I will see if I can find it. Bill ________________________________ From: <thecolemans4@...> < > Sent: Thu, January 13, 2011 7:29:29 PM Subject: Neuropeptide Y Excerpted from CFIDS Association of America newsletter: Researchers at University of Miami and University of Alberta published data comparing levels of neuropeptide Y (NPY) in plasma samples taken from 93 CFS patients, 100 healthy sedentary controls and 37 individuals with Gulf War Illness. NPY levels in CFS patients were higher than in either control group. Levels also correlated with some symptom severity measures, providing the potential for NPY to be used as a biomarker for CFS. The authors state that this data added to other information supports dysregulation of the hypothalamic-pituitary-adrenal axis in CFS, possibly due to infection. This study was funded in part by the CFIDS Association through a grant made in 2006. (Behavioral and Brain Functions) This is one of the biomarkers Bill mentioned that Dr Klimas's group has been working on. Sure would love to get a copy of that study .... anyone seen it? Thanks, Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 14, 2011 Report Share Posted January 14, 2011 Found something... http://www.behavioralandbrainfunctions.com/content/6/1/76 ________________________________ From: Bill klimas <klimas_bill@...> Sent: Fri, January 14, 2011 4:47:24 AM Subject: Re: Neuropeptide Y Â She presented this at a confrence in 2008 maybe 09. I will see if I can find it. Bill ________________________________ From: <thecolemans4@...> < > Sent: Thu, January 13, 2011 7:29:29 PM Subject: Neuropeptide Y Excerpted from CFIDS Association of America newsletter: Researchers at University of Miami and University of Alberta published data comparing levels of neuropeptide Y (NPY) in plasma samples taken from 93 CFS patients, 100 healthy sedentary controls and 37 individuals with Gulf War Illness. NPY levels in CFS patients were higher than in either control group. Levels also correlated with some symptom severity measures, providing the potential for NPY to be used as a biomarker for CFS. The authors state that this data added to other information supports dysregulation of the hypothalamic-pituitary-adrenal axis in CFS, possibly due to infection. This study was funded in part by the CFIDS Association through a grant made in 2006. (Behavioral and Brain Functions) This is one of the biomarkers Bill mentioned that Dr Klimas's group has been working on. Sure would love to get a copy of that study .... anyone seen it? Thanks, Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 14, 2011 Report Share Posted January 14, 2011 That is the paper. The lead author, ann Fletcher is 's partner and the director of the immunology Lab at U of M. ________________________________ From: <thecolemans4@...> Sent: Fri, January 14, 2011 3:30:52 PM Subject: Re: Neuropeptide Y Found something... http://www.behavioralandbrainfunctions.com/content/6/1/76 ________________________________ From: Bill klimas <klimas_bill@...> Sent: Fri, January 14, 2011 4:47:24 AM Subject: Re: Neuropeptide Y She presented this at a confrence in 2008 maybe 09. I will see if I can find it. Bill ________________________________ From: <thecolemans4@...> < > Sent: Thu, January 13, 2011 7:29:29 PM Subject: Neuropeptide Y Excerpted from CFIDS Association of America newsletter: Researchers at University of Miami and University of Alberta published data comparing levels of neuropeptide Y (NPY) in plasma samples taken from 93 CFS patients, 100 healthy sedentary controls and 37 individuals with Gulf War Illness. NPY levels in CFS patients were higher than in either control group. Levels also correlated with some symptom severity measures, providing the potential for NPY to be used as a biomarker for CFS. The authors state that this data added to other information supports dysregulation of the hypothalamic-pituitary-adrenal axis in CFS, possibly due to infection. This study was funded in part by the CFIDS Association through a grant made in 2006. (Behavioral and Brain Functions) This is one of the biomarkers Bill mentioned that Dr Klimas's group has been working on. Sure would love to get a copy of that study .... anyone seen it? Thanks, Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 14, 2011 Report Share Posted January 14, 2011 Hmmm. Reading about neuropeptide Y (wow my OCD really is down considering I haven't read everything on the web about it yet - I need to get my ASO checked - either that or I love Amantadine lol) ... It seems like having this as a marker - at least for a time - is really going to reinforce the whole stress-reaction paradigm of CFS until more studies are available to show how infections can increase it. Obviously they can - it's mentioned in their paper...  So I'll keep looking for it. Surely they're out there. I read in one place where they could inject it directly into the hypothalmus and cause an acute corticotropin-hormone release in the rat brain... I'll have to look, but I think that's one of the stress hormones. I wonder if it's one of the hormones found to feed XMRV that Dr Mikovitz commented on somewhere? Just a thought.  ________________________________ From: Bill klimas <klimas_bill@...> Sent: Fri, January 14, 2011 4:36:09 PM Subject: Re: Neuropeptide Y  That is the paper. The lead author, ann Fletcher is 's partner and the director of the immunology Lab at U of M. ________________________________ From: <thecolemans4@...> Sent: Fri, January 14, 2011 3:30:52 PM Subject: Re: Neuropeptide Y Found something... http://www.behavioralandbrainfunctions.com/content/6/1/76 ________________________________ From: Bill klimas <klimas_bill@...> Sent: Fri, January 14, 2011 4:47:24 AM Subject: Re: Neuropeptide Y She presented this at a confrence in 2008 maybe 09. I will see if I can find it. Bill ________________________________ From: <thecolemans4@...> < > Sent: Thu, January 13, 2011 7:29:29 PM Subject: Neuropeptide Y Excerpted from CFIDS Association of America newsletter: Researchers at University of Miami and University of Alberta published data comparing levels of neuropeptide Y (NPY) in plasma samples taken from 93 CFS patients, 100 healthy sedentary controls and 37 individuals with Gulf War Illness. NPY levels in CFS patients were higher than in either control group. Levels also correlated with some symptom severity measures, providing the potential for NPY to be used as a biomarker for CFS. The authors state that this data added to other information supports dysregulation of the hypothalamic-pituitary-adrenal axis in CFS, possibly due to infection. This study was funded in part by the CFIDS Association through a grant made in 2006. (Behavioral and Brain Functions) This is one of the biomarkers Bill mentioned that Dr Klimas's group has been working on. Sure would love to get a copy of that study .... anyone seen it? Thanks, Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.